https://novapharmanews.com/ 2026-06-05T21:41:27.694Z weekly 1.0 https://novapharmanews.com/about 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/about/data-sources 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/team 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/editorial-policy 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/terms 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/cookie-policy 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/press 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/services 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/drugs 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/companies 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/patents 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/patents/browse 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/patents/expiring 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/patents/assignees 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/patents/granted/recent 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/projects 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/whitepapers 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/events 2026-06-05T21:41:27.694Z weekly 0.7 https://novapharmanews.com/us 2026-06-05T21:41:27.694Z daily 0.9 https://novapharmanews.com/us/news 2026-06-05T21:41:27.694Z hourly 0.85 https://novapharmanews.com/us/articles 2026-06-05T21:41:27.694Z daily 0.8 https://novapharmanews.com/us/events 2026-06-05T21:41:27.694Z daily 0.85 https://novapharmanews.com/us/about 2026-06-05T21:41:27.694Z monthly 0.5 https://novapharmanews.com/us/contact 2026-06-05T21:41:27.694Z monthly 0.5 https://novapharmanews.com/us/privacy-policy 2026-06-05T21:41:27.694Z yearly 0.3 https://novapharmanews.com/eu 2026-06-05T21:41:27.694Z daily 0.9 https://novapharmanews.com/eu/news 2026-06-05T21:41:27.694Z hourly 0.85 https://novapharmanews.com/eu/articles 2026-06-05T21:41:27.694Z daily 0.8 https://novapharmanews.com/eu/events 2026-06-05T21:41:27.694Z daily 0.85 https://novapharmanews.com/eu/about 2026-06-05T21:41:27.694Z monthly 0.5 https://novapharmanews.com/eu/contact 2026-06-05T21:41:27.694Z monthly 0.5 https://novapharmanews.com/eu/privacy-policy 2026-06-05T21:41:27.694Z yearly 0.3 https://novapharmanews.com/apac 2026-06-05T21:41:27.694Z daily 0.9 https://novapharmanews.com/apac/news 2026-06-05T21:41:27.694Z hourly 0.85 https://novapharmanews.com/apac/articles 2026-06-05T21:41:27.694Z daily 0.8 https://novapharmanews.com/apac/events 2026-06-05T21:41:27.694Z daily 0.85 https://novapharmanews.com/apac/about 2026-06-05T21:41:27.694Z monthly 0.5 https://novapharmanews.com/apac/contact 2026-06-05T21:41:27.694Z monthly 0.5 https://novapharmanews.com/apac/privacy-policy 2026-06-05T21:41:27.694Z yearly 0.3 https://novapharmanews.com/us/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/purdue-pharma-shutdown-oxycontin-settlement 2026-06-03 daily 0.8 https://novapharmanews.com/apac/news/fda-approves-auvelity-mdd-new-antidepressant 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/plozasiran-tga-approval-australia-redemplo-fcs 2026-06-05 daily 0.8 https://novapharmanews.com/us/articles/plozasiran-tga-approval-australia-redemplo- FCS 2026-06-05 daily 0.8 https://novapharmanews.com/eu/articles/ema-united-for-health-worldpride-2026 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/dia-2024-regulatory-preview 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/bio-it-world-conference-oncology-day-1 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fierce-biotech-week-highlights-trends 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/us-japan-healthcare-conf-2026-highlights 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/pda-manufacturing-apac-highlights 2026-06-03 daily 0.8 https://novapharmanews.com/apac/news/pda-apac-pharma-manufacturing-day-1-roundup 2026-06-03 daily 0.8 https://novapharmanews.com/apac/news/pda-apac-manufacturing-innovations-day1 2026-06-04 daily 0.8 https://novapharmanews.com/apac/news/pda-apac-manufacturing-day-1-roundup 2026-06-04 daily 0.8 https://novapharmanews.com/apac/news/apac-clinical-event-preview 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/asgct-manufacturing-innovations 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fdli-2026-annual-highlights 2026-06-04 daily 0.8 https://novapharmanews.com/us/news/aphl-2026-highlights-innovations 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/APHL-2026-annual-day-1-roundup 2026-06-03 daily 0.8 https://novapharmanews.com/us/news/fdli-annual-2026-regulatory-insights-policy-updates 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/swiss-biotech-day-key-innovations-partnerships 2026-06-03 daily 0.8 https://novapharmanews.com/eu/news/raps-euro-convergence-regulatory-updates-day-1 2026-06-03 daily 0.8 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0802-phase-2a-trial-steroid-refractory-gvhd 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-veppanu-breast-cancer-diagnostic 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-als-treatment-2024 2026-06-04 daily 0.8 https://novapharmanews.com/apac/news/arrowhead-pharmaceuticals-tga-approval-redemplo-plozasiran-australia-fcs 2026-06-03 daily 0.8 https://novapharmanews.com/eu/news/vanda-pharmaceuticals-nereus-tradipitant-motion-sickness-drug-launch 2026-06-03 daily 0.8 https://novapharmanews.com/eu/news/pulse-biosciences-atrial-fibrillation-treatment-100-percent-success-rate-2026 2026-06-04 daily 0.8 https://novapharmanews.com/eu/news/biocryst-navenibart-european-licensing-deal-neopharmed-gentili 2026-06-03 daily 0.8 https://novapharmanews.com/eu/news/fda-approves-langlara-biosimilar-lantus-insulin-lannett-company 2026-06-03 daily 0.8 https://novapharmanews.com/eu/news/vertex-casgevy-gene-therapy-global-expansion-q1-2026-results 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/crispr-therapeutics-casgevy-global-approvals-60000-patients 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/clene-cnm-au8-fda-accelerated-approval-pathway-als-treatment 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/novartis-fabhalta-health-canada-approval-c3g-treatment 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/alpha-tau-alpha-dart-pancreatic-cancer-trials-ddw-2026 2026-06-03 daily 0.8 https://novapharmanews.com/us/news/celcuity-gedatolisib-phase-3-viktoria-1-trial-pik3ca-mutant-cancer 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-approves-langlara-interchangeable-biosimilar-lantus-insulin-lannett 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-approves-guardant360-cdx-companion-diagnostic-pfizer-veppanu-breast-cancer 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis 2026-06-03 daily 0.8 https://novapharmanews.com/us/news/arvinas-veppanu-vepdegestrant-fda-approval-first-protac-drug-esr1-breast-cancer 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/eular-2026-immutep-imp761-phase-1-preview 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/excipient-world-conference-day-1-highlights 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/ucb-acquires-candid-therapeutics-2-2-billion-t-cell-engager-autoimmune 2026-06-04 daily 0.8 https://novapharmanews.com/us/news/niktimvo-axatilimab-approved-australia-chronic-gvhd-treatment 2026-06-03 daily 0.8 https://novapharmanews.com/us/news/biomarin-voxzogo-achondroplasia-long-term-data-pes-2026 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-approves-incyte-jakafi-xr-extended-release-myelofibrosis-polycythemia-vera 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/apotex-generic-ozempic-semaglutide-health-canada-approval-2026 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/neurocrine-crenessity-two-year-pediatric-cah-study-results 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/novo-nordisk-oral-ozempic-fda-approved-pill-glp1-type-2-diabetes-cardiovascular 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/axsome-auvelity-fda-approval-alzheimers-agitation-treatment 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/arvinas-fda-approval-veppanu-vepdegestrant-protac-esr1-breast-cancer 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/prolacta-human-milk-fortifiers-prescription-drug-status-japan-jasmine-trial 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/uniqure-amt-130-gene-therapy-uk-approval-huntingtons-disease 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/mrm-health-mh002-fda-fast-track-ulcerative-colitis 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/summit-therapeutics-ivonescimab-overall-survival-lung-cancer-asco-2026 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/ac-immune-final-cohort-abate-trial-anti-abeta-alzheimer-treatment 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-advisory-committee-recommends-astrazeneca-truqap-pten-deficient-prostate-cancer 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/eli-lilly-foundayo-orforglipron-fda-approval-obesity-q1-2026-results 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/theradaptive-fda-approval-osteoadapt-sp-phase-3-spinal-fusion-trial 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/immunitybio-securities-fraud-lawsuit-anktiva-fda-warning-letter 2026-06-04 daily 0.8 https://novapharmanews.com/us/news/viking-therapeutics-vk2735-phase-3-obesity-trials-enrolled-q1-2026 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/perimeter-medical-claire-oct-ai-fda-approval-breast-cancer-surgery 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/regeneron-q1-2026-earnings-dupixent-eylea-hd-sales-growth 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/biopharma-clinical-trials-eu-daily-insights 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/clinical-outsourcing-2026-key-takeaways 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/clinical-outsourcing-trends-2026-key-takeaways 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/ieee-cog-2026-industry-day-game-dev-tutorials 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/insilico-rentosertib-inhalation-ind-clearance-ai-drug-clinical-trial 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/european-commission-approves-poherdy-pertuzumab-biosimilar-henlius-organon 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/x4-pharmaceuticals-xolremdi-mavorixafor-european-approval-whim-syndrome 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-whim-syndrome-european-approval 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/norgine-xolremdi-mavorixafor-european-approval-whim-syndrome-treatment 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/henlius-organon-poherdy-first-pertuzumab-biosimilar-approved-europe 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/teva-acquires-emalex-ecopipam-tourette-syndrome-drug 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/pfizer-elrexfio-progression-free-survival-multiple-myeloma-phase-3-trial 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-priority-review-gilead-bictegravir-lenacapavir-hiv-treatment 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/eu-biopharma-clinical-trials-daily-roundup 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-deals-investment 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/pharma-partnering-us-biotech-deals-day-1 2026-06-04 daily 0.8 https://novapharmanews.com/apac/news/claruvis-retoxin-first-recombinant-botulinum-toxin-approval-china 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/silexion-therapeutics-sil204-phase-2-3-trial-kras-pancreatic-cancer 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/aclaris-ati-052-phase-1a-trial-results-45-day-half-life 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/astrazeneca-breztri-aerosphere-approved-first-triple-therapy-asthma-patients-12-older 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/vensica-medical-fda-ind-approval-vixe-xeomin-needle-free-delivery-overactive-bladder 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/abbvie-upadacitinib-rinvoq-fda-application-alopecia-areata 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/chinabio-partnering-forum-biotech-investment-trends 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/ascrs-2026-opus-genetics-phentolamine-preview 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/wuxi-apptec-q1-2026-revenue-growth-backlog-results 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/biomarin-completes-amicus-therapeutics-acquisition-galafold-pompe-therapies 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/opella-essentiale-excel-trial-fatty-liver-disease-masld-results 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/mundipharma-rezzayo-rezafungin-phase-iii-respect-trial-results-fungal-disease-prevention 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/crinetics-palsonify-paltusotine-eu-approval-acromegaly-treatment 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/cellenkos-fda-clearance-ck0801-phase-2-aplastic-anemia-trial 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/intellia-lonvo-z-fda-submission-crispr-hereditary-angioedema 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/intellia-lonvoguran-ziclumeran-phase-3-hereditary-angioedema-gene-editing 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-priority-review-imaavy-nipocalimab-warm-autoimmune-hemolytic-anemia 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-approves-caplyta-lumateperone-snda-schizophrenia-relapse-prevention 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/acrp-2026-patient-centric-trials-workforce 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/reuters-pharma-ai-patient-centricity 2026-06-04 daily 0.8 https://novapharmanews.com/eu/news/reuters-pharma-eu-funding-dealmaking-highlights 2026-06-04 daily 0.8 https://novapharmanews.com/us/news/adagio-medical-vclas-ventricular-ablation-system-pivotal-trial-results 2026-06-04 daily 0.8 https://novapharmanews.com/eu/news/ema-positive-opinion-redemplo-plozasiran-european-approval 2026-06-04 daily 0.8 https://novapharmanews.com/eu/news/ema-approves-first-rna-veterinary-vaccine-nobivac-nxt-cats 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/ema-approves-plozasiran-redemplo-familial-chylomicronaemia-syndrome-fcs 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-approves-otarmeni-first-gene-therapy-genetic-hearing-loss 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/clinuvel-scenesse-phase-iii-vitiligo-trial-ema-approval-2026 2026-06-04 daily 0.8 https://novapharmanews.com/us/news/novartis-coartem-baby-who-prequalification-malaria-treatment-newborns 2026-06-03 daily 0.8 https://novapharmanews.com/apac/news/catalym-visugromab-phase-2-3-trial-cancer-cachexia-first-patient-dosed 2026-06-05 daily 0.8 https://novapharmanews.com/apac/news/spinogenix-spg601-clarity-trial-fragile-x-syndrome-phase-2b-3 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/cortec-brain-interchange-bci-fda-tap-program-stroke-rehabilitation 2026-06-05 daily 0.8 https://novapharmanews.com/us/news/fda-approves-regeneron-otarmeni-gene-therapy-genetic-hearing-loss 2026-06-04 daily 0.8 https://novapharmanews.com/apac/news/minjuvi-tafasitamab-approved-australia-follicular-lymphoma 2026-06-03 daily 0.8 https://novapharmanews.com/eu/news/healthcare-third-party-logistics-market-growth-502-billion-2034 2026-06-04 daily 0.8 https://novapharmanews.com/us/news/mabwell-9mw2821-nectin-4-adc-phase-iii-triple-negative-breast-cancer 2026-06-03 daily 0.8 https://novapharmanews.com/us/news/cipla-fda-approval-first-generic-ventolin-hfa-albuterol-sulfate 2026-06-03 daily 0.8 https://novapharmanews.com/us/news/dupixent-approved-chronic-spontaneous-urticaria-children-sanofi 2026-06-03 daily 0.8 https://novapharmanews.com/us/news/oncology-data-trends-2026-preview 2026-06-05 daily 0.8 https://novapharmanews.com/eu/news/reuters-pharma-day-1-eu-takeaways 2026-06-04 daily 0.8 https://novapharmanews.com/drugs/abacavir-sulfate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/abiraterone-acetate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acamprosate-calcium 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acebutolol-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/aceclidine-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acetaminophen 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acetazolamide 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acetazolamide-sodium 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acetohexamide 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acetylcysteine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acitretin 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acoramidis-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acyclovir 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/acyclovir-sodium 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/adalimumab-aqvh 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/adenosine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/adenovirus-mediated-herpes-simplex-virus-thymidine-kinase-gene 2026-05-26 monthly 0.75 https://novapharmanews.com/drugs/aflibercept 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/agalsidase-alfa 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/albuterol 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/albuterol-sulfate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/alendronate-sodium 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/alirocumab 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/aliskiren 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/allopurinol 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/almotriptan-malate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/alogliptin 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/alogliptin-benzoate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/alosetron-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/alprazolam 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/alvimopan 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amantadine-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amifampridine-phosphate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amiloride-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/aminocaproic-acid 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/aminophylline 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/aminosalicylate-sodium 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amiodarone-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amitriptyline-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amlodipine-benzoate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amlodipine-besylate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/ammonia-n-13 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amoxapine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amoxicillin 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amphetamine-adipate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/amphetamine-aspartate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amphetamine-sulfate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/amphotericin-b 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/ampicillin-sodium 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/ampicillin-ampicillin-trihydrate 2026-05-23 monthly 0.75 https://novapharmanews.com/drugs/anagrelide 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/anagrelide-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/anastrozole 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/apixaban 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/apomorphine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/apremilast 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/aprepitant 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/arformoterol-tartrate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/argatroban 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/arimoclomol-citrate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/aripiprazole 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/armodafinil 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/arsenic-trioxide 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/asparaginase-erwinia-chrysanthemi-recombinant-rywn 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/aspirin 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/atazanavir-sulfate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/atenolol 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/atoltivimab 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/atomoxetine-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/atorvastatin-calcium 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/atovaquone 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/atracurium-besylate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/atropine-sulfate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/avutometinib-potassium 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/axitinib 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/azacitidine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/azathioprine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/azelaic-acid 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/azelastine-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/azilsartan-medoxomil 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/azithromycin 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/baclofen 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/beclomethasone-dipropionate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bempedoic-acid 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/benazepril-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/benzgalantamine-gluconate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/benztropine-mesylate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/beremagene-geperpavec 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/berotralstat 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/berotralstat-dihydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/besilesomab 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/betaine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/betamethasone-acetate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/betamethasone-dipropionate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/betamethasone-valerate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bethanechol-chloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bevacizumab 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bevacizumab-maly 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bexarotene 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bicalutamide 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bimatoprost 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/binimetinib 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bisoprolol-fumarate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bivalirudin 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bleomycin-sulfate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bortezomib 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bosentan 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/brentuximab-vedotin 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/brexpiprazole 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/brigatinib 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/brimonidine-tartrate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/brivaracetam 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bromfenac-sodium 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/brompheniramine-maleate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/budesonide 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bumetanide 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bupivacaine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bupivacaine-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/buprenorphine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/buprenorphine-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/bupropion-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/buspirone-hydrochloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/busulfan 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/butabarbital-sodium 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/c1-inhibitor-human 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/cabazitaxel 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/cabergoline 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/cabozantinib 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/caffeine-citrate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/calcitonin-salmon 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/calcitriol 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/calcium-acetate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/calcium-chloride 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/calcium-gluconate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/calcium-oxybate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/calfactant 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/canagliflozin 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/candesartan-cilexetil 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/cannabidiol 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/cantharidin 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/capecitabine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/captopril 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/carbamazepine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/carbinoxamine-maleate 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/carboplatin 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/carboprost-tromethamine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/carfilzomib 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/carisoprodol 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/carmustine 2026-06-05 monthly 0.75 https://novapharmanews.com/drugs/carvedilol 2026-06-05 monthly 0.75 https://novapharmanews.com/companies/4d-molecular-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/60-degrees-pharmaceuticals-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/abeona-therapeutics-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/abvc-biopharma-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/actuate-therapeutics-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/adc-therapeutics-sa 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/adial-pharmaceuticals-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aeon-biopharma 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/alterity-therapeutics-ltd 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/alx-oncology-holdings-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/an2-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/ani-pharmaceuticals-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/artelo-biosciences-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/assembly-biosciences-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/atossa-therapeutics-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/avenue-therapeutics-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/axim-biotechnologies-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aytu-biopharma-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/acadia-pharmaceuticals-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aclaris-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/acrivon-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/actinium-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/acumen-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/acurx-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/adaptive-biotechnologies-corp 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/addex-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/agios-pharmaceuticals-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/agomab-therapeutics-nv 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/akari-therapeutics-plc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/akebia-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aktis-oncology 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/alaunos-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aldeyra-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aligos-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/allarity-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/allogene-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/mira-pharmaceuticals-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/alnylam-pharmaceuticals-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/altamira-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/amneal-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/amphastar-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/amylyx-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/anebulo-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/nika-pharmaceuticals-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/anixa-biosciences-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/apellis-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/apimeds-pharmaceuticals-us 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/apogee-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aprea-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aptevo-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aptose-biosciences 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aquestive-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/arbutus-biopharma-corp 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/arcturus-therapeutics-holdings 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/arcus-biosciences 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/arcutis-biotherapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aardvark-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/armata-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/arrivent-biopharma 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/arrowhead-pharmaceuticals-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/ars-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/artiva-biotherapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aspire-biopharma-holdings 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/atea-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/atrium-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aura-biosciences 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/aurinia-pharmaceuticals 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/autolus-therapeutics-plc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/avalo-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/axsome-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/beone-medicines 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/bicycle-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/brainstorm-cell-therapeutics-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/bright-minds-biosciences-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/barinthus-biotherapeutics-plc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/beam-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/benitec-biopharma 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/bicara-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/biomarin-pharmaceutical-inc 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/bioxcel-therapeutics 2026-06-03 monthly 0.75 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/fixed-dose-combination-of-telmisartan-amlodipine-hypertension 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/nintedanib-lung-diseases-interstitial 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/dabigatran-etexilate-venous-thromboembolism 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/empagliflozin-myocardial-infarction 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/iclepertin-schizophrenia 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/nintedanib-idiopathic-pulmonary-fibrosis 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-201335-hepatitis-c 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/dabigatran-dose-1-atrial-fibrillation 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/insulin-icodec-diabetes-type-2 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/empagliflozin-heart-failure 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/somapacitan-growth-hormone-deficiency-in-children 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/afatinib-head-and-neck-neoplasms 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/linagliptine-5-mg-diabetes-mellitus-type-2 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/metformin-diabetes-mellitus-type-2 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/biphasic-insulin-aspart-diabetes 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/liraglutide-diabetes 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/biphasic-insulin-aspart-30-diabetes 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/brigimadlin-liposarcoma-dedifferentiated 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/rosuvastatin-systemic-lupus-erythematosus 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/concizumab-haemophilia-a-without-inhibitors 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/faster-acting-insulin-aspart-diabetes 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/insulin-detemir-diabetes 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/chinese-university-of-hong-kong/projects/amlodipine-telmisartan-amiloride-compound-simvas-essential-hypertension 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/liraglutide-metabolism-and-nutrition-disorder 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/oral-semaglutide-diabetes-mellitus-type-2 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/semaglutide-overweight 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/afatinib-carcinoma-non-small-cell-lung 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/linagliptin-diabetes-mellitus-type-2 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/janssen-cilag-international-nv/projects/tramadol-hci-acetaminophen-cancer 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/janssen-cilag-international-nv/projects/tacrolimus-dermatitis-atopic 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/bupivacaine-injection-marcaine-acute-pain 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital/projects/typhoid-vi-vaccine-typhoid 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/the-university-of-hong-kong/projects/cinacalcet-kidney-failure 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ianalumab-primary-immune-thrombocytopenia 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/united-therapeutics-corp/projects/ut-15c-treprostinil-diolamine-pulmonary-arterial-hypertension 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/vera-therapeutics/projects/pregabalin-pain-postoperative 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/semnur-pharmaceuticals/projects/ixabepilone-capecitabine-breast-cancer 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/bi-201335-hepatitis-c-chronic 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/roche-registration-limited/projects/erlotinib-non-squamous-non-small-cell-lung-cancer 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/roche-registration-limited/projects/lebrikizumab-asthma 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/concizumab-haemophilia-a-with-inhibitors 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/ianalumab-primary-immune-thrombocytopenia-itp 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-hidradenitis-suppurativa 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/eptacog-alfa-activated-acquired-bleeding-disorder 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/insulin-degludec-insulin-aspart-diabetes 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/insulin-degludec-diabetes 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/merck-serono-europe-limited/projects/vericiguat-chronic-heart-failure-with-reduced-ejection-frac 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/roche-registration-limited/projects/pioglitazone-diabetes-mellitus-type-2 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/centocor-b-v/projects/placebo-injections-rheumatoid-arthritis 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/abbvie-ltd/projects/placebo-ulcerative-colitis-uc 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/bayer-healthcare-ag/projects/regorafenib-bay73-4506-colorectal-neoplasms 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/nonacog-beta-pegol-congenital-bleeding-disorder 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/vinflunine-stomach-cancer 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/semaglutide-diabetes 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/abbvie-ltd/projects/upadacitinib-ulcerative-colitis 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/somapacitan-growth-hormone-disorder 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novartis-ophthalmics-europe/projects/lcz696-sacubitril-valsartan-acute-myocardial-infarction 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/astrazeneca/projects/metformin-type-2-diabetes 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/empagliflozin-chronic-kidney-disease 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/mira-pharmaceuticals-inc/projects/pidotimod-recurrent-respiratory-tract-infections 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/turoctocog-alfa-congenital-bleeding-disorder 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/turoctocog-alfa-pegol-congenital-bleeding-disorder 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/group-c-saline-propofol-group-urologic-surgery 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/control-hallucinations-verbal-auditory 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/amgen-technology-ireland-uc/projects/evolocumab-coronary-heart-disease-chd 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/intraosseous-morphine-pain-postoperative 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/sanofi-pasteur/projects/risedronate-sodium-osteoporosis-postmenopausal 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/astrazeneca/projects/budesonide-formoterol-turbuhaler-asthma 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/bristol-myers-squibb-pharma-eeig-eu/projects/stavudine-efavirenz-lamivudine-hiv-infections 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/gain-therapeutics/projects/combined-fixed-dose-combination-tuberculosis 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/cellseed-europe-ltd/projects/cls2901c-human-allogeneic-chondrocyte-sheets-osteoarthritis-of-the-knee 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/hospital-authority-hong-kong/projects/empagliflozin-10-mg-diabetic-nephropathies 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/novo-mesto/projects/rosiglitazone-diabetes 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/vera-therapeutics/projects/peginterferon-alfa-2a-hepatitis-b-chronic 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/mylan-ire-healthcare-limited/projects/trastuzumab-breast-cancer 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/pfizer/projects/pregabalin-and-celecoxib-chronic-low-back-pain-with-a-neuropathic-compone 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/atara-biotherapeutics/projects/clopidogrel-coronary-artery-disease 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/grace-therapeutics/projects/imiquimod-5-cream-superficial-basal-cell-carcinoma 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/astrazeneca/projects/baxdrostat-uncontrolled-hypertension 2026-05-26 monthly 0.65 https://novapharmanews.com/companies/boehringer-ingelheim-international-gmbh/projects/olodaterol-bi-1744-pulmonary-disease-chronic-obstructive 2026-05-26 monthly 0.65 https://novapharmanews.com/patents/us/7060837 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7060259 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7060712 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7060733 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7060256 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7060276 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7060442 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7060689 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7060686 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7060688 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7060703 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7061237 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7060672 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7060827 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7060466 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7060113 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7060824 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7064112 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7064106 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7064141 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7063840 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7063847 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7064181 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7067317 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7067256 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7067633 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7067661 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7067122 2026-05-23 monthly 0.62 https://novapharmanews.com/patents/us/7067635 2026-06-05 monthly 0.62 https://novapharmanews.com/patents/us/7067254 2026-06-05 monthly 0.62